Ambu A/S (OTCMKTS:AMBBY) Posts Earnings Results

Ambu A/S (OTCMKTS:AMBBY) announced its quarterly earnings data on Wednesday. The company reported $0.07 EPS for the quarter, Zacks reports. The business had revenue of $246.39 million during the quarter. Ambu A/S had a return on equity of 9.15% and a net margin of 8.86%.

Ambu A/S Price Performance

Shares of OTCMKTS:AMBBY remained flat at $9.98 during midday trading on Thursday. The stock had a trading volume of 600 shares, compared to its average volume of 159. The firm has a market cap of $2.35 billion, a price-to-earnings ratio of 32.19 and a beta of 1.06. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.67 and a current ratio of 2.86. Ambu A/S has a twelve month low of $9.70 and a twelve month high of $16.78. The company’s 50-day moving average is $10.91 and its 200 day moving average is $12.78.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.